Approval Of The Comparative Study Between ReCOV And mRNA Vaccines By FDA In The Philippines ...Middle East

News by : (PR Newswire) -
TAIZHOU, China, Aug. 3, 2022 /PRNewswire/ -- Jiangsu Recbio Technology Co., Ltd. (the"Company", together with its subsidiaries, the "Group",Stock code:02179.HK) is pleased to announce that, the Company has recently received the clinical trial approval for its recombinant protein COVID-19...

Read More Details
Finally We wish PressBee provided you with enough information of ( Approval Of The Comparative Study Between ReCOV And mRNA Vaccines By FDA In The Philippines )

Also on site :

Most Viewed News
جديد الاخبار